Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2011
07/07/2011US20110166343 Thienopyrazole derivative having pde7 inhibitory activity
07/07/2011US20110166175 7-azaindole derivatives
07/07/2011US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors
07/07/2011US20110166170 Synthesis of avrainvillamide, stephacidin b, and analogues thereof
07/07/2011US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof
07/07/2011US20110166152 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
07/07/2011US20110166146 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
07/07/2011US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors
07/07/2011US20110166129 Inhibitors of janus kinases
07/07/2011US20110166124 Tricyclic spirocycle derivatives and methods of use
07/07/2011US20110166123 Novel compositions and methods of use
07/07/2011US20110166116 New compounds, pharmaceutical composition and methods relating thereto
07/07/2011US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators
07/07/2011US20110165691 Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions
07/07/2011US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof
07/07/2011US20110165075 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
07/07/2011CA2786089A1 Nitrogen-containing heterocyclic compound and agricultural fungicide
07/07/2011CA2785749A1 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
07/07/2011CA2785536A1 Substituted imidazopyridinyl-aminopyridine compounds
07/07/2011CA2784768A1 Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
07/07/2011CA2784152A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
07/06/2011EP2340251A1 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use
07/06/2011EP2340250A1 Selective glycosidase inhibitors and uses thereof
07/06/2011EP2340244A1 Compounds and methods of use
07/06/2011EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
07/06/2011EP1492765B1 Novel gamma secretase inhibitors
07/06/2011CN1953982B 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones
07/06/2011CN1918149B Novel chelating agents and highly luminescent and stable chelates and their use
07/06/2011CN1867549B Cyclopropyl derivatives as NK3 receptor antagonists
07/06/2011CN102119163A Diazacarbazoles and methods of use
07/06/2011CN102119162A Diazacarbazoles and methods of use
07/06/2011CN102119047A Heteroaryl derivatives as DGAT1 inhibitors
07/06/2011CN102115473A Bis-heterocyclic imidazolyl compounds
07/06/2011CN102115472A 3-(2-pyrromethene)azaindoline-2-one derivatives and preparation method and application thereof
07/06/2011CN102115470A Pyrimidine small-molecular compounds, and preparation method and application thereof
07/06/2011CN102115469A Preparation method for indoline-2-one derivative and application of same
07/06/2011CN102114430A Catalyst and preparation method thereof as well as method for preparing N-alkylpyrrole derivatives
07/06/2011CN101381365B Dual action antibiotics
07/06/2011CN101357915B Diazabicyclic central nervous system active agents
07/06/2011CN101203517B 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
07/05/2011US7973163 Fused quinoline derivative and use thereof
07/05/2011US7973160 Nitrogen-containing aromatic derivatives
07/05/2011US7973057 Thalidomide analogs
07/05/2011US7973050 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly
07/05/2011US7973047 Beta-Secretase modulators and methods of use
07/05/2011US7973033 Multi-cyclic cinnamide derivatives
07/05/2011US7973030 Benzothiazepine and benzothiepine compounds
07/05/2011CA2618840C Pyrazolone derivatives
07/05/2011CA2531484C Novel bioisosteres of actinonin
07/05/2011CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
07/05/2011CA2474386C Integrin targeted imaging agents
06/2011
06/30/2011WO2011079296A2 Photoconductive sensor materials for detection of explosive vapor
06/30/2011WO2011079274A1 Aminopyrimidine kinase inhibitors
06/30/2011WO2011079133A2 Compounds and methods for kinase modulation, and indications therefor
06/30/2011WO2011079076A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
06/30/2011WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
06/30/2011WO2011079023A1 Methoxatin derivatives
06/30/2011WO2011078984A1 [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof
06/30/2011WO2011078226A1 Tricyclic compound
06/30/2011WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same
06/30/2011WO2011077098A1 Inhibitors of akt activity
06/30/2011WO2011076747A1 Diaza-spiro[5.5]undecanes as orexin receptor antagonists
06/30/2011WO2011076744A1 Disubstituted heteroaryl-fused pyridines
06/30/2011WO2011076419A1 Imidazopyridine derivatives as jak inhibitors
06/30/2011WO2011076316A1 Pyrrolopyridinyl-pyrimidin-2-ylamine derivatives
06/30/2011WO2011056566A3 Compounds and methods for treatment of cancer
06/30/2011WO2011045383A3 2, 6 -diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases
06/30/2011US20110160451 2-Aminopyrimidine modulators of the histamine H4 receptor
06/30/2011US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
06/30/2011US20110160242 Purified Pyrroloquinolinyl-Pyrrolidine-2,5-Dione Compositions And Methods For Preparing And Using Same
06/30/2011US20110160240 Polymorphs and salts of a kinase inhibitor
06/30/2011US20110160237 Substituted Heterocyclic Compounds
06/30/2011US20110160233 Anti-viral compounds
06/30/2011US20110160229 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
06/30/2011US20110160227 Prolyl Hydroxylase Inhibitors
06/30/2011US20110160217 Deuterium enriched analogues of tadalafil as pde5 inhibitors
06/30/2011US20110160210 Control of intraocular pressure using alk5 modulation agents
06/30/2011US20110160208 Diaryl-substituted five-membered heterocycle derivative
06/30/2011US20110160204 PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS
06/30/2011US20110160201 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it
06/30/2011US20110160183 Inhibitors of akt activity
06/30/2011US20110160182 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/30/2011US20110158989 Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS
06/30/2011US20110155247 Organic Semiconductors and Devices Incorporating Same
06/30/2011DE112009001852T5 Photoelektrisches Wandlerelement A photoelectric conversion element
06/30/2011DE102009060174A1 Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate Pyrrolopyridinyl-pyrimidin-2-yl-amine derivatives
06/30/2011CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
06/30/2011CA2785439A1 [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof
06/30/2011CA2785307A1 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
06/30/2011CA2785113A1 Imidazopyridine derivatives as jak inhibitors
06/30/2011CA2784393A1 Compounds and methods for kinase modulation, and indications therefor
06/30/2011CA2783575A1 Aminopyrimidine kinase inhibitors
06/30/2011CA2783340A1 Inhibitors of akt activity
06/30/2011CA2781780A1 Novel antiviral compounds
06/29/2011EP2338889A1 Diazacyclic compounds having affinity for opioid receptors
06/29/2011EP2338888A1 Imidazopyridine derivatives as JAK inhibitors
06/29/2011EP2338879A1 New phenylhydrazone derivatives and their use as pharmaceuticals
06/29/2011EP2338487A1 Combination therapy with PARP inhibitors
06/29/2011EP2146986B1 Diphenyl-dihydro-imidazopyridinones
06/29/2011EP2074122B1 Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors